Literature DB >> 7227969

Thyrotropin-daunomycin conjugate shows receptors-mediated cytotoxicity in cultured thyroid cells.

Y Kaneko.   

Abstract

Daunomycin (DM), a potent chemotherapeutic agent, was linked to bovine thyrotropin (TSH) directly (TSH-DM) and indirectly (TSH-alpha-lactalbumin-DM) by covalent cross-linking methods. The activity of these hormone-daunomycin conjugates was tested in vitro on the rabbit thyroid cells in primary culture. Both TSH-DM and TSH-alpha-lactalbumin-DM conjugates inhibited [3H]leucine incorporation and cell proliferation, while free TSH did not. Their inhibitory action was more potent than that of free daunomycin. The inhibition appeared to be specific to the thyroid cells and diminished in the presence of a large amount of free TSH, suggesting that the cytotoxic action of these TSH-DM conjugates was a receptor-mediated phenomenon.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7227969     DOI: 10.1055/s-2007-1019187

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.

Authors:  A Trouet; M Masquelier; R Baurain; D Deprez-De Campeneere
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

2.  Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex.

Authors:  S Vitols; K Söderberg-Reid; M Masquelier; B Sjöström; C Peterson
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

3.  Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft.

Authors:  D J Kerr; A Rogerson; G J Morrison; A T Florence; S B Kaye
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.